Clinical Trial

A Study Describing the Efficacy and Safety of Belimumab Administered in Adult Participants With Early Systemic Lupus Erythematosus (SLE)

Name: A Study Describing the Efficacy and Safety of Belimumab Administered in Adult Participants With Early Systemic Lupus Erythematosus (SLE) — clinical trial record (NCT06411249)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 4

View on ClinicalTrials.gov →

Summary

This is a prospective, open-label, single arm 3-year clinical study to describe the short-term and long-term efficacy and safety of belimumab in participants with autoantibody positive early SLE with ongoing disease activity despite stable first-line SLE therapy.

Trial Details

NCT Number	NCT06411249
Lead Sponsor	GlaxoSmithKline
Conditions	Systemic Lupus Erythematosus
Enrollment	350 participants
Start Date	2024-06-06
Primary Completion	2027-05-31 (estimated)
Study Completion	2029-05-29 (estimated)
Updated on ClinicalTrials.gov	2026-06-03